Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

Evaluation of seven Cholestech L.D.X analyzers for total cholesterol determinations.

Rogers EJ, Misner L, Ockene IS, Nicolosi RJ.

Clin Chem. 1993 May;39(5):860-4.

2.
3.

Evaluation of lipid profile measurements obtained from the Cholestech L.D.X analyzer.

Bard RL, Kaminsky LA, Whaley MH, Zajakowski S.

J Cardiopulm Rehabil. 1997 Nov-Dec;17(6):413-8.

PMID:
9421763
4.

Inaccuracy of lipid measurements with the portable Cholestech L.D.X analyzer in patients with hypercholesterolemia.

Stein JH, Carlsson CM, Papcke-Benson K, Einerson JA, McBride PE, Wiebe DA.

Clin Chem. 2002 Feb;48(2):284-90.

5.

An evaluation of two compact analyzers used for lipid analysis.

McKenney JM, Fary DF, Miller G, Proctor JD, Chinchili VM.

J Fam Pract. 1993 May;36(5):526-33.

PMID:
8482937
6.

Analytic and clinical performance of two compact cholesterol-testing devices.

Volles DF, McKenney JM, Miller WG, Ruffen D, Zhang D.

Pharmacotherapy. 1998 Jan-Feb;18(1):184-92.

PMID:
9469692
7.

[Precision and accuracy of blood lipid analyses by a portable device (Cholestech-LDX)].

Issa JS, Strunz C, Giannini SD, Forti N, Diament J.

Arq Bras Cardiol. 1996 Jun;66(6):339-42. Portuguese.

PMID:
9035449
8.

Accuracy of three dry-chemistry methods for lipid profiling and risk factor classification.

Rubin DA, McMurray RG, Harrell JS, Carlson BW, Bangdiwala S.

Int J Sport Nutr Exerc Metab. 2003 Sep;13(3):358-68.

PMID:
14669935
9.

Precision of a dry-chemistry method of lipid screening.

Bowden RG, Kingery PM, Long L.

Public Health. 2006 Jun;120(6):572-6. Epub 2006 May 26.

PMID:
16730036
10.

Comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments.

Dale RA, Jensen LH, Krantz MJ.

Ann Pharmacother. 2008 May;42(5):633-9. doi: 10.1345/aph.1K688. Epub 2008 Apr 15.

PMID:
18413684
11.

Reliability of the Reflotron in the determination of cholesterol.

Selmer R, Foss OP, Lund-Larsen PG.

Scand J Clin Lab Invest. 1990 May;50(3):261-71.

PMID:
2353155
12.

Eight compact analysis systems evaluated for measuring total cholesterol.

Gregory LC, Duh SH, Christenson RH.

Clin Chem. 1994 Apr;40(4):579-85.

13.

Total error assessment of five methods for cholesterol screening.

Miller WG, McKenney JM, Conner MR, Chinchilli VM.

Clin Chem. 1993 Feb;39(2):297-304.

14.

Reflotron performance in a community screening program: results of the Massachusetts Model Systems for Blood Cholesterol Screening Project.

Havas S, Bishop R, Koumjian L, Reisman J, Wozenski S.

Am J Prev Med. 1991 Nov-Dec;7(6):397-405.

PMID:
1790049
15.

External quality-control survey of cholesterol analyses performed by 12 lipid research clinics.

Lippel K, Ahmed S, Albers JJ, Bachorik P, Muesing R, Winn C.

Clin Chem. 1978 Sep;24(9):1477-84.

16.

Implementation of cellulomonas cholesterol oxidase for total serum cholesterol determination by the endpoint method.

Srisawasdi P, Chaichanajarernkul U, Teerakranjana N, Kroll MH.

J Clin Lab Anal. 2008;22(1):50-8. doi: 10.1002/jcla.20221.

PMID:
18200584
17.

Blood cholesterol concentration: fingerstick plasma vs venous serum sampling.

Greenland P, Bowley NL, Meiklejohn B, Doane KL, Sparks CE.

Clin Chem. 1990 Apr;36(4):628-30. Erratum in: Clin Chem 1990 Aug;36(8 Pt 1):1530.

19.

Analytical quality of near-patient blood cholesterol and glucose determinations.

du Plessis M, Ubbink JB, Vermaak WJ.

Clin Chem. 2000 Aug;46(8 Pt 1):1085-90.

Supplemental Content

Support Center